Literature DB >> 2375246

Clinical course and long-term prognosis of acute transverse myelopathy.

P B Christensen1, L Wermuth, H H Hinge, K Bømers.   

Abstract

The clinical characteristics and course of acute transverse myelopathy (ATM) was studied. One patient developed multiple sclerosis. In 1 patient ATM was caused by tumour-cell embolization of the intramedullar vessels; 30 aged 12-74 years (median 36 years) had ATM of unknown course, of these, 13 had symptoms of a preceding viral-like infection, 18 had back-pain and 10 signs of spinal shock. The time from onset of ATM to maximum deficit varied from less than 1 h to 20 days. The thoracic region was the most common level of cord damage. Follow-up was possible in 29 cases; 2 died (2 and 8 months after onset), of the surviving 27 (follow-up 1-13 years, median 6 years) one third had a good outcome, one third a fair, while one third remained paraplegic, incontinent with severe sensory deficits. Back-pain and signs of spinal shock indicated a poor outcome.

Entities:  

Mesh:

Year:  1990        PMID: 2375246     DOI: 10.1111/j.1600-0404.1990.tb00990.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  23 in total

1.  Progressive ascending myelopathy: atypical forms of multiple sclerosis or what else?

Authors:  Viviana Nociti; Anna Paola Batocchi; Marco Luigetti; Amelia Conte; Vita Santa Lorusso; Silvia Roiati; Tommaso Tartaglione; Alessandra Del Grande; Mario Sabatelli
Journal:  J Neurol       Date:  2011-04-22       Impact factor: 4.849

2.  Neurological and functional recovery in acute transverse myelitis patients with inpatient rehabilitation and magnetic resonance imaging correlates.

Authors:  A Gupta; S N Kumar; A B Taly
Journal:  Spinal Cord       Date:  2016-03-01       Impact factor: 2.772

3.  Acute transverse myelitis in demyelinating diseases among the Chinese.

Authors:  R Li; W Qiu; Z Lu; Y Dai; A Wu; Y Long; Y Wang; J Bao; X Hu
Journal:  J Neurol       Date:  2011-05-18       Impact factor: 4.849

4.  The clinical course of idiopathic acute transverse myelitis in patients from Rio de Janeiro.

Authors:  Marina Papais Alvarenga; Luiz Claudio Santos Thuler; Silvio Peçanha Neto; Claudia Cristina Ferreira Vasconcelos; Solange Gomes Camargo; Marcos Papais Alvarenga; Regina Maria Papais-Alvarenga
Journal:  J Neurol       Date:  2010-02-03       Impact factor: 4.849

5.  MRI in acute transverse myelopathy.

Authors:  S Holtås; N Basibüyük; K Fredriksson
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

6.  Long-term outcome of acute and subacute myelopathies.

Authors:  S Debette; J de Sèze; J-P Pruvo; H Zephir; F Pasquier; D Leys; P Vermersch
Journal:  J Neurol       Date:  2009-02-28       Impact factor: 4.849

7.  Prevalence and characteristics of transverse myelitis and neuromyelitis optica spectrum disorders in the United Arab Emirates: A multicenter, retrospective study.

Authors:  Kathryn B Holroyd; Faisal Aziz; Miklos Szolics; Taoufik Alsaadi; Michael Levy; Nicoline Schiess
Journal:  Clin Exp Neuroimmunol       Date:  2018-05-07

Review 8.  Demyelinating disorders: update on transverse myelitis.

Authors:  Chitra Krishnan; Adam I Kaplin; Carlos A Pardo; Douglas A Kerr; Sanjay C Keswani
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 6.030

9.  Idiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choices.

Authors:  Amer Awad; Olaf Stüve
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

10.  Effective management of intractable neuropathic pain using an intrathecal morphine pump in a patient with acute transverse myelitis.

Authors:  Wei-Ting Wu; Yu-Hui Huang; Der-Cherng Chen; Yu-Hsuan Huang; Li-Wei Chou
Journal:  Neuropsychiatr Dis Treat       Date:  2013-07-29       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.